IMEGLIMIN: 151 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
151
Total FAERS Reports
8 (5.3%)
Deaths Reported
85
Hospitalizations
151
As Primary/Secondary Suspect
8
Life-Threatening
1
Disabilities
Active Ingredient: IMEGLIMIN HYDROCHLORIDE ·
First Report: 20040101 · Latest Report: 20250901
What Are the Most Common IMEGLIMIN Side Effects?
#1 Most Reported
Glycosylated haemoglobin increased
37 reports (24.5%)
#2 Most Reported
Nausea
26 reports (17.2%)
#3 Most Reported
Lactic acidosis
25 reports (16.6%)
All IMEGLIMIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Glycosylated haemoglobin increased | 37 | 24.5% | 3 | 21 |
| Nausea | 26 | 17.2% | 0 | 16 |
| Lactic acidosis | 25 | 16.6% | 0 | 21 |
| Decreased appetite | 21 | 13.9% | 0 | 16 |
| Diabetic ketoacidosis | 17 | 11.3% | 0 | 16 |
| Diarrhoea | 14 | 9.3% | 0 | 7 |
| Vomiting | 14 | 9.3% | 0 | 9 |
| Blood glucose increased | 13 | 8.6% | 2 | 7 |
| Diabetes mellitus inadequate control | 13 | 8.6% | 0 | 6 |
| Dehydration | 11 | 7.3% | 0 | 9 |
| Renal impairment | 11 | 7.3% | 0 | 3 |
| Blood triglycerides increased | 10 | 6.6% | 0 | 6 |
| Contraindicated product administered | 10 | 6.6% | 1 | 5 |
| Low density lipoprotein increased | 10 | 6.6% | 0 | 7 |
| High density lipoprotein decreased | 9 | 6.0% | 0 | 5 |
| Weight decreased | 9 | 6.0% | 0 | 4 |
| Blood pressure systolic increased | 8 | 5.3% | 1 | 4 |
| Alanine aminotransferase increased | 6 | 4.0% | 1 | 1 |
| Altered state of consciousness | 6 | 4.0% | 0 | 6 |
| Aspartate aminotransferase increased | 6 | 4.0% | 1 | 0 |
Who Reports IMEGLIMIN Side Effects? Age & Gender Data
Gender: 45.9% female, 54.1% male. Average age: 66.3 years. Most reports from: JP. View detailed demographics →
Is IMEGLIMIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2004 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 0 |
| 2021 | 10 | 0 | 9 |
| 2022 | 20 | 2 | 10 |
| 2023 | 34 | 2 | 23 |
| 2024 | 15 | 1 | 11 |
| 2025 | 7 | 2 | 3 |
What Is IMEGLIMIN Used For?
| Indication | Reports |
|---|---|
| Type 2 diabetes mellitus | 112 |
| Product used for unknown indication | 18 |
| Diabetes mellitus | 15 |
IMEGLIMIN vs Alternatives: Which Is Safer?
IMEGLIMIN vs IMETELSTAT
IMEGLIMIN vs IMIDAPRIL
IMEGLIMIN vs IMIGLUCERASE
IMEGLIMIN vs IMIPENEM
IMEGLIMIN vs IMIPRAMINE
IMEGLIMIN vs IMIQUIMOD
IMEGLIMIN vs IMITREX
IMEGLIMIN vs IMMUNE GLOBULIN NOS
IMEGLIMIN vs IMPLANON
IMEGLIMIN vs INAVOLISIB
Official FDA Label for IMEGLIMIN
Official prescribing information from the FDA-approved drug label.